More on InVivo Therapeutics Q2 results

InVivo Therapeutics Holdings Corp. (OTCQB:NVIV +1.2%) Q2 results: Revenues: $0; Operating Expenses: $4.7M (-6.6%); Operating Loss: ($4.7M) (+6.6%); Net Loss: ($3.6M) (+74.5%); Loss Per Share: ($0.04) (+80.0%); Quick Assets: $20.9M (+49.3%).

No guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs